Leland Gershell

Stock Analyst at Oppenheimer

(0.96)
# 1981
Out of 5,329 analysts
149
Total ratings
40.71%
Success rate
-2.80%
Average return
46 Stocks
Name Action PT Current % Upside Ratings Updated
QNCX Quince Therapeutics
Initiates Coverage On: Outperform
10
1.07 834.58% 1 Mar 24, 2025
TRVI Trevi Therapeutics
Maintains: Outperform
12 20
6.92 189.02% 3 Mar 11, 2025
ARGX argenx
Maintains: Outperform
675 704
638.88 10.19% 6 Feb 28, 2025
BMRN Biomarin Pharmaceuti...
Upgrades: Outperform
98
62.7 56.3% 3 Feb 24, 2025
RYTM Rhythm Pharmaceutica...
Initiates Coverage On: Outperform
76
63.8 19.12% 1 Dec 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
190 180
166.64 8.02% 10 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
48 52
21.88 137.66% 2 Nov 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
135 147
109.02 34.84% 2 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
5 5
0.52 861.54% 8 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 Nov 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
65 73
75.12 -2.82% 8 Oct 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
40 40
11.47 248.74% 9 Oct 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
47 53
15.96 232.08% 3 Oct 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Perform
n/a
n/a n/a 1 Oct 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 43
12.82 235.41% 4 Sep 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
30 30
3.65 721.92% 2 Sep 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
12 12
1.7 605.88% 2 Sep 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
150 25
0.52 4707.69% 9 Sep 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
31 28
13.74 103.78% 5 Aug 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
30 25
3.44 626.74% 3 Aug 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
74 73
33.6 117.26% 7 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
16 13
n/a n/a 5 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
14 20
1.54 1198.7% 5 Jul 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
29 29
24.32 19.24% 3 Jun 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
35
5.04 594.44% 2 Apr 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
10 10
0.75 1233.33% 1 Apr 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
5
4.49 11.36% 1 Mar 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
23 20
1.32 1415.15% 3 Nov 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 7 Oct 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
16 13
1.32 884.85% 3 Apr 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
150 120
3.79 3066.23% 1 Mar 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 1 Oct 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 Aug 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
140
n/a n/a 1 Mar 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
36
n/a n/a 4 Dec 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
42
n/a n/a 1 Dec 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
12
n/a n/a 1 Sep 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
360000
n/a n/a 1 Jun 4, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Perform
n/a
n/a n/a 2 Mar 15, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Perform
n/a
n/a n/a 2 Nov 25, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
50
1.99 2412.56% 1 Oct 23, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
4620 1470
n/a n/a 2 Sep 25, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
225
n/a n/a 1 Aug 25, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
112 115
n/a n/a 2 May 12, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Perform
16 17
n/a n/a 2 May 5, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Perform
n/a
n/a n/a 4 Mar 31, 2020